Know Cancer

or
forgot password
  • cancer clinical trials in connecticut

  • Assessing Ear Damage in Young Cancer Patients Treated With Cisplatin
    Yale Cancer Center
    New Haven, Connecticut 06520-8028
    Ototoxicity, Unspecified Childhood Solid Tumor, Protocol Specific
    Randomized Phase II Study of Preoperative Letrozole (Femara) in Combination With Avastin in Hormone Receptor Positive Breast Cancer
    Yale University, Yale Cancer Center
    New Haven, Connecticut 06520
    Hormone-Sensitive Breast Cancer, Breast Cancer
    Trial of Gemcitabine, Carboplatin, and Sorafenib in Chemotherapy-naive Patients With Advanced/Metastatic Bladder Carcinoma
    Yale University, Comprehensive Cancer Center
    New Haven, Connecticut 06520
    Bladder Cancer
    VEGF Trap in Treating Patients With Recurrent or Persistent Endometrial Cancer
    Hartford Hospital

    Trial Locations
    Hartford Hospital
    The Hospital of Central Connecticut
    Recurrent Endometrial Carcinoma
    Component and Couple Analysis of Cancer Communications
    Hartford Hospital
    Hartford, Connecticut 06102-5037
    Breast Cancer
    A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
    Connecticut Children's Medical Center Dept of Dermatology

    Trial Locations
    Connecticut Children's Medical Center Dept of Dermatology
    Yale University School Of Medicine
    Atopic Dermatitis
    Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
    Bendheim Cancer Center at Greenwich Hospital

    Trial Locations
    Bendheim Cancer Center at Greenwich Hospital
    Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
    Neurotoxicity Syndromes, Pain, Peripheral Neuropathy, Unspecified Adult Solid Tumor, Protocol Specific
    Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer
    Saint Francis Hospital and Medical Center

    Trial Locations
    Saint Francis Hospital and Medical Center
    The Hospital of Central Connecticut
    Endometrial Cancer
    1st or 2nd Line MBC (Metastatic Breast Cancer) With Previous Avastin (Bevacizumab) Therapy
    Oncology Associates of Bridgeport
    Trumball, Connecticut 06611
    Breast Cancer
    Adj TC + Herceptin Early Stage Breast Cancer
    Connecticut Oncology & Hematology, LLP
    Torrington, Connecticut 06790
    Breast Cancer
    Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer
    St. Vincent's Medical Center

    Trial Locations
    St. Vincent's Medical Center
    Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
    Lung Cancer
    Phase 2b Study of Taxol Plus Sorafenib or Placebo in Patients With Advanced Breast Cancer
    Eastern Connecticut Hematology and Oncology Associates

    Trial Locations
    Eastern Connecticut Hematology and Oncology Associates
    Medical Oncology and Hematology, PC at Harold Leever Cancer Center
    Breast Cancer
    Megestrol in Treating Patients With Endometrial Neoplasia or Endometrial Hyperplasia
    George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus
    New Britain, Connecticut 06050
    Endometrial Cancer, Precancerous Condition
    IGIV Study for Chronic ITP Patients Ages 3-70
    Connecticut Children's Medical Center

    Trial Locations
    Connecticut Children's Medical Center
    Cancer Center of Central Connecticut
    Idiopathic Thrombocytopenic Purpura
    CHESS: Human and Computer Mentors for Prostate Cancer Patients
    Hartford Hospital
    Hartford, Connecticut 06102-5037
    Prostate Cancer
    First-Line Chemotherapy and Trastuzumab With or Without Bevacizumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER-2/NEU
    Eastern Connecticut Hematology and Oncology Associates
    Norwich, Connecticut 06360
    HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer
    Selumetinib in Treating Woman With Recurrent Low-Grade Ovarian Cancer or Peritoneum Cancer
    Hartford Hospital

    Trial Locations
    Hartford Hospital
    The Hospital of Central Connecticut
    Borderline Ovarian Surface Epithelial-stromal Tumor, Ovarian Serous Cystadenocarcinoma, Primary Peritoneal Cavity Cancer, Recurrent Borderline Ovarian Surface Epithelial-stromal Tumor
    Epratuzumab and Rituximab in Treating Patients With Previously Untreated Follicular Non-Hodgkin Lymphoma
    Middlesex Hospital Cancer Center
    Middletown, Connecticut 06457
    Lymphoma
    Carboplatin, Paclitaxel and Gemcitabine With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer
    Hartford Hospital

    Trial Locations
    Hartford Hospital
    Saint Francis Hospital and Medical Center
    The Hospital of Central Connecticut
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer
    Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer
    Middlesex Hospital Cancer Center

    Trial Locations
    Middlesex Hospital Cancer Center
    George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus
    William W. Backus Hospital
    Prostate Cancer
    Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor
    Eastern Connecticut Hematology and Oncology Associates
    Norwich, Connecticut 06360
    Neuroendocrine Carcinoma
    AMG 706 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus
    New Britain, Connecticut 06050
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
    University of Connecticut

    Trial Locations
    University of Connecticut
    Saint Francis Hospital and Medical Center
    The Hospital of Central Connecticut
    Yale University
    Eastern Connecticut Hematology and Oncology Associates
    Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Salivary Gland Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Salivary Gland Squamous Cell Carcinoma, Stage IV Salivary Gland Cancer, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IV Verrucous Carcinoma of the Larynx, Stage IV Verrucous Carcinoma of the Oral Cavity, Tongue Cancer, Untreated Metastatic Squamous Neck Cancer With Occult Primary
    Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients
    Nowalk Hospital
    Norwalk, Connecticut 06856
    Acute Myeloid Leukemia
    A Study of XL184 (Cabozantinib) With or Without Erlotinib in Adults With Non-Small Cell Lung Cancer
    Yale University School Of Medicine
    New Haven, Connecticut 06520
    Carcinoma, Non-Small-Cell Lung
    Phase II Sunitinib Prog Met AIPC
    Connecticut Oncology & Hematology, LLP
    Torrington, Connecticut 06790
    Metastatic Prostate Cancer
    Study of Nifurtimox to Treat Refractory or Relapsed Neuroblastoma or Medulloblastoma
    Connecticut Children's Hospital
    Hartford, Connecticut 06106
    Neuroblastoma, Medulloblastoma
    Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
    Hartford Hospital

    Trial Locations
    Hartford Hospital
    Saint Francis Hospital and Medical Center
    Middlesex Hospital
    Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IV Breast Cancer